期刊文献+

挤出-滚圆法制备枸橼酸莫沙必利骨架缓释微丸 被引量:9

Preparation of Mosapride Citrate Sustained-release Matrix Pellets by Extrusion-spheronization Technique
下载PDF
导出
摘要 目的制备枸橼酸莫沙必利骨架缓释微丸,研制枸橼酸莫沙必利新剂型。方法采用挤出-滚圆法制备枸橼酸莫沙必利骨架缓释微丸,考察润湿剂用量、挤出速度及滚圆速度对释放度的影响,并通过加速试验考察制剂的稳定性。结果枸橼酸莫沙必利骨架缓释微丸的释药动力学符合Higuchi方程,制剂稳定性良好。结论本方法制备枸橼酸莫沙必利骨架缓释微丸工艺可靠,质量可控。 Objective To prepare mosapride citrate sustained-release matrix pellets and develop a new dosage form of mosapride citrate.Methods Extrusion-spheronization technique was introduced to prepare mosapride citrate sustained-release matrix pellets.The effect of the amount of wetting agent,extrusion speed and spheronization speed on drug release was investigated and the stability of the preparation was also studied by accelerated test.Results The release profiles of mosapride citrate sustained-release matrix pellets followed Higuchi equation and the stability of the preparation was satisfactory.Conclusion The preparation technology is reliable and the quality is controllable.
作者 李欣 刘琳娜
出处 《解放军药学学报》 CAS 2010年第1期4-6,共3页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 枸橼酸莫沙必利 骨架缓释微丸 挤出滚圆 释放度 mosapride citrate sustained-release matrix pellets Extrusion-spheronization drug release
  • 相关文献

参考文献4

  • 1Ruth M,Hamelin B,Rǒhss K,et al.The effect of mosapride,a novel prokinetic,on acid reflux variables in patients with gastro-oesophageal reflux disease[J].Aliment Pharmacol Ther,1998,12(1):35-40.
  • 2Mine Y,Yoshikawa T,Oku S,et al.Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro[J].J Pharmacol Exp Ther,1997,283(3):1000-1008.
  • 3张婷,王敏伟.胃肠动力药的发展及展望[J].国外医药(合成药.生化药.制剂分册),2002,23(5):274-276. 被引量:10
  • 4蔡翠芳,毕殿洲,毛世瑞.挤出滚圆法制备氢溴酸右美沙芬骨架缓释微丸[J].沈阳药科大学学报,2003,20(5):313-320. 被引量:15

二级参考文献12

  • 1钱方,蒋雪涛,王安文.微丸的进展[J].中国医药工业杂志,1996,27(1):41-46. 被引量:29
  • 2陆彬.药物新剂型新技术 [M].北京:人民卫生出版社,1998.292-294.
  • 3雷招宝.科宁溶液 [J].中国新药杂志,1997,6(4):262-262.
  • 4陈新谦.新编药物学 [M].北京:人民卫生出版社,1992.272.
  • 5Munoz A, Guichard JP, Regirnault Ph. Micronised fenofibrate [J]. Atherosclerosis. 1994. 110(suppl. ) :45 - 48.
  • 6Shepherd James. The fibrate in clinical practice: focus on micronised fenofibrate [J]. Atherosclerosis, 1994,110(suppl.)55-63
  • 7Sheu Ming-Thau, Yeh Ching-Min. Dissolution studies of fenofibrate in the ethaolic medium [J]. The Chinese Pharmaceutical Journal, 1993, 45 (1) : 43 - 51.
  • 8Sheu Ming-Thau, Yeh Ching-Min, Sokoloski Theodore D.Characterization and dissolution of fenofibrate solid dispersion systems[J]. Int J Pharm. 1994.103 : 137 - 146.
  • 9Kere J, Srcie S, Knez Z, et al. Micronization of drugs using carbon dioxide [J]. Int J Pharm, 1999,182:33 - 39.
  • 10潘家祯,孙晓明,朱大滨,陈庆华,包泳初,陈挺.挤出滚圆法制备药用微丸 Ⅰ.设备的工作原理及特点[J].中国医药工业杂志,1998,29(8):378-380. 被引量:35

共引文献23

同被引文献96

引证文献9

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部